The metaverse hype is over, but developer Cassette Group has been working with Pfizer to realise its forgotten potential.
Hosted on MSN10h
Pharma Stock Roundup: J&J's ITCI Buyout, LLY's Weak Q4 SalesKey Takeaways JNJ will buy Intra-Cellular Therapies, producer of a drug for bipolar disorder, for $14.6 billion. Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback